Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Pick a track — progress rings update as you complete lessons.
7 lessons
9mTesamorelin has one of the cleanest human-data stories in the peptide space. The new liver fat trial matters because it asks whether that signal extends into fatty liver disease.
8mScale weight is noisy. If you are using retatrutide, waist trend, body composition, protein intake, and strength matter more than a single weigh-in.
8mTesamorelin has one of the stronger human-data profiles in the peptide space. A 2026 meta-analysis helps clarify what it improves, what it does not, and how to track the signal honestly.
9mAlready on Reta and ready to add compounds? Here's how to stack Tesamorelin and MOTS-C with Retatrutide for maximum fat loss and recomp.
10mMost fat-loss compounds either suppress appetite or boost energy expenditure. 5-Amino-1MQ does something different — it blocks the enzyme that burns through your NAD+ and keeps fat cells from ever getting broken down. Here's why it stacks so well with Reta and MOTS-C.
9mTesamorelin is an FDA-approved GHRH analog with clinical trials proving 15–20% visceral fat reduction. Here's the full science, dosing guide, and what the latest research reveals about its longevity applications.
8mDiscover Tesamorelin, the only FDA-approved GHRH peptide, specifically indicated for reducing visceral fat.
Also available at /blog for legacy links.